Cantor Fitzgerald Reiterates Overweight on Perspective Therapeutics
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Louis Chen has reiterated an Overweight rating on Perspective Therapeutics (AMEX:CATX).
September 03, 2024 | 2:03 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Cantor Fitzgerald's analyst Louis Chen has reiterated an Overweight rating on Perspective Therapeutics, suggesting a positive outlook for the stock.
The reiteration of an Overweight rating by a reputable analyst can boost investor confidence and potentially lead to a short-term increase in the stock price of Perspective Therapeutics.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100